BIOPHTA Email Formats

Pharmaceutical Manufacturing • Paris, Île-de-France, France • 1-10 Employees

BIOPHTA Email Formats

BIOPHTA uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@biophta.com), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@biophta.com	66.7%
{first initial}.{last name}	j.doe@biophta.com	33.3%

Key Contacts at BIOPHTA

Jean Garrec

Founder & Ceo

Jean Cuiné

Chief Technology Officer & Board Member

Kristell Lebozec

Cmc Director

Valentin T. Fleury

Member Of The Board Of Directors

Hélène Pfister

Cmc Project Director

Company overview

Headquarters	BIOLABS campus Broussais, 8, rue Maria Helena Vieira Da Silva, Paris, 75014, FR
Websites	biophta.com synology.me
NAICS	3254
Keywords	Biotechnology, Drug Development, Retina, Ophthalmology, Glaucoma, Biopolymers, Macular Edema, Drug Delivery Platform
Founded	2020
Employees	1-10
Socials

About BIOPHTA

World Health Organization evaluates between 200 and 300 million, the number of people who are visually impaired by diseases against which pharmaceutical treatments are however existing. Many of these conditions have in common to cause permanent vision loss if they are not treated consistently. The lack of adherence to prescription eye drops is the #1 Unmet Medical need in Ophthalmology. Poor treatment Compliance and Adhesion leads to a worse progression of Eye Diseases. BIOPHTA wants to change the lives of patients suffering from chronic eye diseases by creating a best-in-class solution to reduce the burden of treatments. We develop a new way of treating the eye, with a novel pharmaceutical platform enabling a continuous Drug Delivery. Our topical Mucoadhesive Ocular Hydrogel Insert releases drugs on the eye for a one-week period, causing higher efficacy & potency for medications. These Ocular Inserts will help patients to improve their adherence to treatment regimens. It also permits a better yield of the drugs by diminishing the frequency and complexity of eye drops application while generating a continuous and controlled sustained release. BIOPHTA non-invasive topical ocular inserts are aimed at several ophthalmic indications by allowing better long-term control of diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

BIOPHTA has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore BIOPHTA's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-07-03	3	$7,100,000

Funding Insights

$7,100,000

Total funding amount

$7,100,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

BIOPHTA is located in Paris, Île-de-France, FR.

BIOPHTA was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

BIOPHTA has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

BIOPHTA has raised a total of $7,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.